Zinc Thymulin

Mechanism (as reported)

Across the provided studies, thymulin is described as a zinc-dependent metallopeptide whose biological activity and antigenicity depend on the presence of zinc in the molecule; zinc coupling is associated with a specific three-dimensional conformation/epitope and is implicated in effects on intra- and extrathymic T cell differentiation and T-cell functions.

Key findings (each cites a source)

• Thymulin is a nonapeptide hormone produced by thymic epithelial cells. [PMID 2657247, 18476235, 32363520, 3262625, 1618588, 19236333]
• Thymulin’s biological activity depends strictly on the presence of zinc in the molecule (zinc-dependent metallopeptide). [PMID 2657247, 18476235, 2413455, 1618588, 3262625, 32363520, 19236333, 1967043]
• Zinc-dependent thymulin activity is associated with a specific three-dimensional conformation/structure and a zinc-coupled epitope recognized by monoclonal antibodies; NMR findings are reported to align with this zinc-containing unique structure. [PMID 18476235, 2413455, 1618588, 19236333]
• Serum thymulin activity decreases in mild zinc deficiency and is corrected after zinc supplementation in experimental human models; this was suggested as a sensitive indicator of zinc deficiency. [PMID 18476235, 3262625]
• In mild zinc deficiency models, changes in T-cell–related parameters (including lymphocyte subpopulation measures and IL-2 activity) were reported during the zinc depletion phase and corrected after repletion with zinc. [PMID 3262625]
• In rats, serum thymulin activity showed greater sensitivity to restricted zinc intake than four other zinc-status measures that were also assessed (serum zinc, extracellular superoxide dismutase, serum 5’-nucleotidase activity, and liver metallothionein). [PMID 32363520]
• The zinc/thymulin relationship has been studied using experimental models of mild zinc deficiency in animals and humans; serum thymulin activity decreased with zinc deficiency and was corrected by zinc supplementation (in vivo and in vitro). [PMID 18476235]
• Thymulin is described as inducing intra- and extra-thymic T cell differentiation and affecting T-cell functions, with suppressor T-cell effects described as especially remarkable in one study. [PMID 2657247, 18476235, 1618588, 19236333]
• In Crohn’s disease, plasma zinc levels are reported to be significantly lower than in matched controls, with reduced active thymulin and an increase in the inactive form; in vitro addition of zinc ions restored thymulin activity and shifted the inactive/active forms. [PMID 1967043]
• Thymic endocrinology literature describes thymulin as one of the putative thymic hormones that circulates and acts on prothymocytes and mature T-cells in the periphery, and reports that thymic hormones (exemplified by the zinc-thymulin complex) can be secreted under stimulation (e.g., by IL-1) within the thymic endocrine milieu. [PMID 1618588]
• A review article reports that thymulin production and secretion are influenced by the neuroendocrine system and discusses thymulin’s involvement in intrathymic/extrathymic T cell differentiation; it also describes therapeutic potential literature. [PMID 19236333]